Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

Overview of attention for article published in EJNMMI Research, May 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Wikipedia Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Study of the production of radioisotopes at IFMIF-DONES: 177Lu with deuterons

Article in Radiation Physics and Chemistry (July 2024)

Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of Radioimmunoconjugates

Article in Journal of Medicinal Chemistry (September 2023)

Glypican1: A potential cancer biomarker for nanotargeted therapy

Article in Drug Discovery Today (June 2023)